drug manufacturers news from FierceHealthcare
News
ALSO NOTED: US drugmakers face financial downgrades next year; Providers getting on board with NPI quickly; and much more...
> Next year could be a grim one financially for U.S. drug manufacturers, who can expect to see their credit ratings drop thanks to patent expirations, generic competition and regulatory Read more...
Express Scripts pays $9.5M settlement over drug switching
Pharmacy benefit manager Express Scripts has agreed to pay a total of $9.5 million to 28 states and the District of Columbia to settle allegations that it engaged in deceptive prescription-switching Read more...
SPOTLIGHT: FDA can't manage foreign drugmaker inspections
A new report from the Government Accountability Office has concluded that the FDA doesn't have the resources to properly inspect foreign companies that manufacture drugs or drug ingredients. At Read more...
Paid Research Reports
- Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse events with drug-eluting stents demand a new safety standard
- Impact of Pharmacogenomics on Public Healthcare Policy
- The Cardiovascular Disorders Market Outlook to 2012
- 2008 Trends to Watch: Pharmaceutical Technology
- Pharmaceutical Pricing and Reimbursement: Strategies for market access across the US, Europe, Japan and other key geographies